ArticleNeurocritical care2026
Trajectories of daily inpatient blood biomarkers of physiological function improve mortality and morbidity prognostic model performance for patients with severe traumatic brain injury.
Article in Neurocritical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe sought to assess the prognostic value of incorporating daily inpatient physiological biomarker trajectories to the International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) model for mortality and morbidity six months after severe traumatic brain injury (TBI).
methodsPatients with severe TBI (presenting Glasgow Coma Scale ≤ 8) were prospectively collected in a single-center database (n = 598). Morbidity (yes/no) was defined as Glasgow Outcome Scale Extended of 1-4. Daily blood labs (e.g., glucose, sodium, platelets, hemoglobin, neutrophils, lymphocytes, creatinine, blood urea nitrogen) were extracted for the first 14 days after injury. IMPACT was compared with IMPACT-extended (IMPACT + daily lab trajectories) for area under the curve (AUC). Net reclassification index (NRI) assessed the number of correctly reclassified cases for IMPACT-extended compared with IMPACT.
resultsIMPACT-extended had a better AUC than IMPACT for mortality (AUC 0.93 vs. 0.84, P < 0.001) and morbidity (AUC 0.84 vs. 0.80, P < 0.001). NRI analyses revealed IMPACT-extended improved correct classifications of patients who survived to 6 months by 41%. NRI analyses revealed that IMPACT-extended modestly improved correct classification of controls by 4% compared with IMPACT.
conclusionsIncorporating trajectories for daily blood biomarkers of physiological function significantly improves the discrimination and clinically relevant performance of existing prognostic models for both morbidity and mortality six months following severe TBI.
Indexed as
Identifiers
41507677What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.